"AlphaFold's Psychedelic Predictions: A Breakthrough for Drug Discovery?"

AlphaFold, an AI tool developed by DeepMind, has been used to identify hundreds of thousands of potential new psychedelic molecules, showing its potential in drug discovery. While some skepticism remains, studies have found that AlphaFold's predictions can be as useful as experimental models in identifying promising drugs. The tool's ability to predict protein structures could revolutionize drug discovery, although it may not be universally applicable. Isomorphic Labs, a spin-off of DeepMind, is ramping up drug-discovery efforts using AlphaFold, and the company has announced deals with pharmaceutical giants to utilize machine-learning tools for drug development.